iCoreConnect Inc. (NASDAQ: ICCT), a leader in cloud-based software and technology solutions, has announced an expanded partnership with the Mississippi Dental Association (MDA). The MDA now endorses seven of iCoreConnect’s products, extending its initial endorsement of the company’s cloud-based electronic prescribing software, iCoreRx.
In 2020, the MDA began endorsing iCoreConnect’s iCoreRx software, including its Electronic Prescribing for Controlled Substances (EPCS) feature. Following its successful integration across the MDA’s membership, the association has added six more of iCoreConnect’s products to help enhance members’ revenue cycle management.
Along with iCoreRx, the MDA now endorses:
iCoreVerify - Automated insurance verification
iCoreCodeGenius - Fast ICD-10 coding
iCoreClaims - Dental claims and billing
iCorePay - Statements, payments, and billing solutions
iCoreAcademy - Patient education video library
Robert McDermott, CEO of iCoreConnect, expressed excitement about the partnership, stating, "The Mississippi Dental Association has been a fantastic partner for the past four years. We’re excited to offer these key products to their members, furthering our mission to create a platform that streamlines revenue cycle management, infrastructure, and patient experience for dental practices."
The MDA takes pride in its comprehensive endorsement program, thoroughly vetting its partners. Wahnee Sherman, Executive Director of the MDA, commented, “We’ve observed iCoreConnect’s dedication and growth over the years. These endorsed products will significantly benefit our members, improving both revenue generation and patient satisfaction.”
iCoreConnect is actively engaged in continuing education, networking, and practice management support for dental professionals, aligning well with the needs of state dental associations. With the growth of its endorsements, iCoreConnect now reaches around 155,000 dental professionals nationwide, offering a strong lead generation platform and distribution channel for its current and future products.
